Celltrend GmbH
Records under this name other than the patents Celltrend GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 4 of 4 · Back to Celltrend GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,802,020 | Diagnosis of Chronic Fatigue Diseases Using Detection Antibodies Directed Against a β-ADRENERGIC Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 8,110,374 | Method for predicting the risk of transplant rejection and immunological testkit Term ended Term ended May 24, 2024 · From the USPTO record | Term ended | Term ended May 24, 2024 | From the USPTO record |
| US 8,846,324 | In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor Lapsed on the fee record Ended Sep 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2022 | From the USPTO record |
| US 8,999,338 | Method for diagnosis for multiple sclerosis involving anti1-receptor antibody Lapsed on the fee record Ended Apr 7, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 7, 2019 | From the USPTO record |